Esperance Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile


Baton Rouge, LA USA
Total Funding:$28.7M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Esperance Pharmaceuticals's estimated annual revenue is currently $2.6M per year.(?)
  • Esperance Pharmaceuticals's estimated revenue per employee is $201,000
  • Esperance Pharmaceuticals's total funding is $28.7M.

Employee Data

  • Esperance Pharmaceuticals has 13 Employees.(?)
  • Esperance Pharmaceuticals currently has 1 job openings.

Esperance Pharmaceuticals, Inc. is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell's surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs.